Literature DB >> 33593864

The 5 Pillars in Tourette Syndrome Deep Brain Stimulation Patient Selection: Present and Future.

Davide Martino1, Wissam Deeb2, Joohi Jimenez-Shahed2, Irene Malaty2, Tamara M Pringsheim2, Alfonso Fasano2, Christos Ganos2, Winifred Wu2, Michael S Okun2.   

Abstract

The selection of patients with Tourette syndrome (TS) for deep brain stimulation (DBS) surgery rests on 5 fundamental pillars. However, the operationalization of the multidisciplinary screening process to evaluate these pillars remains highly diverse, especially across sites. High tic severity and tic-related impact on quality of life (first 2 pillars) require confirmation from objective, validated measures, but malignant features of TS should per se suffice to fulfill this pillar. Failure of behavioral and pharmacologic therapies (third pillar) should be assessed taking into account refractoriness through objective and subjective measures supporting lack of efficacy of all interventions of proven efficacy, as well as true lack of tolerability, adherence, or access. Educational interventions and use of remote delivery formats (for behavioral therapies) play a role in preventing misjudgment of treatment failure. Stability of comorbid psychiatric disorders for 6 months (fourth pillar) is needed to confirm the predominant impact of tics on quality of life, to prevent pseudo-refractoriness, and to maximize the future DBS response. The 18-year age limit (fifth pillar) is currently under reappraisal, considering the potential impact of severe tics in adolescence and the predictive effect of tic severity in childhood on tic severity when transitioning into adulthood. Future advances should aim at a consensus-based definition of failure of specific, noninvasive treatment strategies for tics and of the minimum clinical observation period before considering DBS treatment, the stability of behavioral comorbidities, and the use of a prospective international registry data to identify predictors of positive response to DBS, especially in younger patients.
© 2021 American Academy of Neurology.

Entities:  

Mesh:

Year:  2021        PMID: 33593864      PMCID: PMC8105965          DOI: 10.1212/WNL.0000000000011704

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  56 in total

1.  Patient selection and assessment recommendations for deep brain stimulation in Tourette syndrome.

Authors:  James Poysky; Joohi Jimenez-Shahed
Journal:  Mov Disord       Date:  2007-07-15       Impact factor: 10.338

2.  Detecting a clinically meaningful change in tic severity in Tourette syndrome: a comparison of three methods.

Authors:  Sangchoon Jeon; John T Walkup; Douglas W Woods; Alan Peterson; John Piacentini; Sabine Wilhelm; Lily Katsovich; Joseph F McGuire; James Dziura; Lawrence Scahill
Journal:  Contemp Clin Trials       Date:  2013-08-31       Impact factor: 2.226

3.  Paediatric deep brain stimulation: ethical considerations in malignant Tourette syndrome.

Authors:  Rosemary T Behmer Hansen; Arjun Dubey; Cynthia Smith; Patrick J Henry; Antonios Mammis
Journal:  J Med Ethics       Date:  2020-05-04       Impact factor: 2.903

4.  Double-blind clinical trial of thalamic stimulation in patients with Tourette syndrome.

Authors:  Linda Ackermans; Annelien Duits; Chris van der Linden; Marina Tijssen; Koen Schruers; Yasin Temel; Mariska Kleijer; Pieter Nederveen; Richard Bruggeman; Selma Tromp; Vivianne van Kranen-Mastenbroek; Herman Kingma; Danielle Cath; Veerle Visser-Vandewalle
Journal:  Brain       Date:  2011-03       Impact factor: 13.501

5.  Real-World Experience With VMAT2 Inhibitors.

Authors:  Nicki Niemann; Joseph Jankovic
Journal:  Clin Neuropharmacol       Date:  2019 Mar/Apr       Impact factor: 1.592

6.  A trial of scheduled deep brain stimulation for Tourette syndrome: moving away from continuous deep brain stimulation paradigms.

Authors:  Michael S Okun; Kelly D Foote; Samuel S Wu; Herbert E Ward; Dawn Bowers; Ramon L Rodriguez; Irene A Malaty; Wayne K Goodman; Donald M Gilbert; Harrison C Walker; Jonathan W Mink; Stacy Merritt; Takashi Morishita; Justin C Sanchez
Journal:  JAMA Neurol       Date:  2013-01       Impact factor: 18.302

7.  Tic disorders and ADHD: answers from a world-wide clinical dataset on Tourette syndrome.

Authors:  Roger D Freeman
Journal:  Eur Child Adolesc Psychiatry       Date:  2007-06       Impact factor: 4.785

8.  Understanding disability in Tourette syndrome.

Authors:  Tamara Pringsheim; Anthony Lang; Roger Kurlan; Michelle Pearce; Paul Sandor
Journal:  Dev Med Child Neurol       Date:  2008-10-24       Impact factor: 5.449

9.  Efficacy and Safety of Deep Brain Stimulation in Tourette Syndrome: The International Tourette Syndrome Deep Brain Stimulation Public Database and Registry.

Authors:  Daniel Martinez-Ramirez; Joohi Jimenez-Shahed; James Frederick Leckman; Mauro Porta; Domenico Servello; Fan-Gang Meng; Jens Kuhn; Daniel Huys; Juan Carlos Baldermann; Thomas Foltynie; Marwan I Hariz; Eileen M Joyce; Ludvic Zrinzo; Zinovia Kefalopoulou; Peter Silburn; Terry Coyne; Alon Y Mogilner; Michael H Pourfar; Suketu M Khandhar; Man Auyeung; Jill Louise Ostrem; Veerle Visser-Vandewalle; Marie-Laure Welter; Luc Mallet; Carine Karachi; Jean Luc Houeto; Bryan Timothy Klassen; Linda Ackermans; Takanobu Kaido; Yasin Temel; Robert E Gross; Harrison C Walker; Andres M Lozano; Benjamin L Walter; Zoltan Mari; William S Anderson; Barbara Kelly Changizi; Elena Moro; Sarah Elizabeth Zauber; Lauren E Schrock; Jian-Guo Zhang; Wei Hu; Kyle Rizer; Erin H Monari; Kelly D Foote; Irene A Malaty; Wissam Deeb; Aysegul Gunduz; Michael S Okun
Journal:  JAMA Neurol       Date:  2018-03-01       Impact factor: 18.302

Review 10.  The effects of Gilles de la Tourette syndrome and other chronic tic disorders on quality of life across the lifespan: a systematic review.

Authors:  Joel Evans; Stefano Seri; Andrea E Cavanna
Journal:  Eur Child Adolesc Psychiatry       Date:  2016-02-15       Impact factor: 4.785

View more
  5 in total

1.  Efficacy of deep brain stimulation of the anterior-medial globus pallidus internus in tic and non-tic related symptomatology in refractory Tourette syndrome.

Authors:  Raven Kisten; Riaan van Coller; Nafisa Cassimjee; Elsa Lubbe; Janardan Vaidyanathan; Pieter Slabbert; Nico Enslin; Clara Schutte
Journal:  Clin Park Relat Disord       Date:  2022-08-03

2.  Improved depressive symptoms in patients with refractory Gilles de la Tourette syndrome after deep brain stimulation of posteroventral globus pallidus interna.

Authors:  Aijun Liu; Yongcheng Jiao; Shaohui Zhang; Haibo Kong
Journal:  Brain Behav       Date:  2022-05-27       Impact factor: 3.405

Review 3.  Tourette syndrome research highlights from 2021.

Authors:  Andreas Hartmann; Per Andrén; Cyril Atkinson-Clement; Virginie Czernecki; Cécile Delorme; Nanette Marinette Debes; Natalia Szejko; Keisuke Ueda; Kevin Black
Journal:  F1000Res       Date:  2022-06-29

Review 4.  Tourette Syndrome Treatment Updates: a Review and Discussion of the Current and Upcoming Literature.

Authors:  Jessica Frey; Irene A Malaty
Journal:  Curr Neurol Neurosci Rep       Date:  2022-02-02       Impact factor: 6.030

Review 5.  European clinical guidelines for Tourette syndrome and other tic disorders-version 2.0. Part IV: deep brain stimulation.

Authors:  Natalia Szejko; Yulia Worbe; Andreas Hartmann; Veerle Visser-Vandewalle; Linda Ackermans; Christos Ganos; Mauro Porta; Albert F G Leentjens; Jan-Hinnerk Mehrkens; Daniel Huys; Juan Carlos Baldermann; Jens Kuhn; Carine Karachi; Cécile Delorme; Thomas Foltynie; Andrea E Cavanna; Danielle Cath; Kirsten Müller-Vahl
Journal:  Eur Child Adolesc Psychiatry       Date:  2021-10-04       Impact factor: 4.785

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.